ACUTE AND CHRONIC ACTIVE ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: PROGNOSIS AND TREATMENT

被引：0
|
作者：
Yilmaz, Vural Taner [1 ]
Kocak, Huseyin [1 ]
Suleymanlar, Gultekin [1 ]
Cetinkaya, Ramazan [1 ]
Akkaya, Bahar [2 ]
Akbas, Halide [3 ]
Koksoy, Sadi [4 ]
Kisaoglu, Abdullah [5 ]
Aydinli, Bulent [5 ]
机构：
[1] Akdeniz Univ, Sch Med, Dept Internal Med, Div Nephrol, Antalya, Turkey
[2] Akdeniz Univ, Sch Med, Dept Pathol, Antalya, Turkey
[3] Akdeniz Univ, Sch Med, Dept Biochem, Antalya, Turkey
[4] Akdeniz Univ, Sch Med, Dept Clin Immunol, Antalya, Turkey
[5] Akdeniz Univ, Sch Med, Dept Gen Surg, Antalya, Turkey
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P499
引用
收藏
页码：527 / 527
页数：1
相关论文
共 50 条
  • [41] Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
    Peter W. Nickerson
    Georg A. Böhmig
    Steve Chadban
    Deepali Kumar
    Roslyn B. Mannon
    Teun van Gelder
    James C. Lee
    Scott Adler
    Edward Chong
    Arjang Djamali
    [J]. Trials, 23
  • [42] Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients.
    Kincaide, E.
    Hitchman, K.
    Hall, R.
    Yamaguchi, I.
    Crowther, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 715 - 715
  • [43] Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients
    Kincaide, Elisabeth
    Hitchman, Kelley
    Hall, Reed
    Yamaguchi, Ikuyo
    Ding, Yanli
    Crowther, Barrett
    [J]. PEDIATRIC TRANSPLANTATION, 2019, 23 (08)
  • [44] To Treat or Not To Treat: Late Antibody Mediated Rejection in Kidney Transplant Recipients
    Diskin, D.
    Williams, T.
    Reed, R.
    Locke, J.
    Mannon, R.
    Gaston, R.
    Kumar, V.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 436 - 436
  • [45] Retrospective Analysis of Kidney Transplant Recipients with Antibody-Mediated Rejection
    Pineiro, G.
    Desousa, E.
    Villarreal, J.
    Lozano, M.
    Cid, J.
    Sole, M.
    Oppenheimer, F.
    Diekmann, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 536 - 536
  • [46] To Treat or Not To Treat: Late Antibody Mediated Rejection in Kidney Transplant Recipients
    Diskin, D.
    Williams, T.
    Reed, R.
    Locke, J.
    Mannon, R.
    Gaston, R.
    Kumar, V.
    [J]. TRANSPLANTATION, 2014, 98 : 436 - 436
  • [47] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [48] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Yeo, Sang Mok
    Park, Hayeon
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 527 - 527
  • [49] Antibody-based protocol for the treatment of chronic antibody mediated kidney transplant rejection.
    Samaniego, M.
    Pascual, J.
    Djamali, A.
    Torrealba, J.
    Zachariah, M.
    Voss, B.
    Sollinger, H.
    Pirsch, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 260 - 260
  • [50] Treatment of late antibody mediated rejection in renal transplant recipients
    Galliford, J.
    Shiu, K.
    Chan, K.
    England, M.
    Cook, T.
    McLean, A.
    Warrens, A.
    Taube, D.
    Dorling, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 442 - 443
12345